Filing Details
- Accession Number:
- 0000950170-24-052873
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-03 16:05:10
- Reporting Period:
- 2024-05-02
- Accepted Time:
- 2024-05-03 16:05:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1463361 | Unity Biotechnology Inc. | UBX | Pharmaceutical Preparations (2834) | 264726035 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1807437 | Anirvan Ghosh | C/O Unity Biotechnology, Inc. 285 East Grand Avenue South San Francisco CA 94080 | Chief Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value | Disposition | 2024-05-02 | 603 | $1.55 | 78,143 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares sold by the Reporting Person pursuant to a Rule 10b5-1 trading instruction to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- Includes Restricted Stock Units which vest over time measured from the grant date.
Billionaire Hedge Funds
